The careful transportation and storage of pharmaceuticals, biologics, and other temperature-sensitive products in a controlled setting across the whole supply chain is referred to as “cold chain logistics” in the healthcare industry. This process ensures that these products maintain their safety and effectiveness all the way from the production process to the final user, who could be a patient or a healthcare professional. The cold chain logistics infrastructure comprises refrigerated trucks, warehouses, and packaging solutions equipped with temperature-monitoring devices to maintain the required temperature range. For many pharmaceuticals, this range is between 2°C and 8°C, and for some biologics and vaccines, it can be as low as ultra-low.
According to SPER market research, ‘Europe Healthcare Cold Chain Logistics Market Size – By Product, By Services, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Europe Healthcare Cold Chain Logistics Market is predicted to reach USD 23.98 billion by 2033 with a CAGR of 9.98%.
Drivers:
OTC pharmaceutical use is expected to rise dramatically. Customers’ awareness of health issues has clearly increased in Europe during the pandemic. By giving people more power and facilitating easier access to healthcare services, self-care can help with these problems. In European healthcare, these variables have played a role in the growth of cold chain logistics. Because people are taking a more proactive approach to managing their health, there is a greater need for over-the-counter (OTC) medications and self-care products. Consequently, the expansion of online shopping portals has increased consumer accessibility to over-the-counter medication use in Europe. The reason for the market’s expansion is the ease with which healthcare products can be purchased through electronic channels.
Challenges:
The intricacy of storing and transporting medications, biologics, and medical equipment at temperature-sensitive levels is one of the primary issues facing the European healthcare cold chain logistics sector. Strict temperature control must be maintained to guarantee the safety and effectiveness of medical products at every stage of the supply chain, from production to delivery and distribution. Temperature variations that occur when these goods are being stored or transported may damage them, lessen their effectiveness, or even have negative effects on patients.
Request For Free Sample Report @ https://www.sperresearch.com/report-store/europe-healthcare-cold-chain-logistics-market.aspx?sample=1
Impact of COVID-19 on Europe Healthcare Cold Chain Logistics Market
The COVID-19 pandemic has presented both opportunities and problems for the Europe Healthcare Cold Chain Logistics Market. Cold chain logistics services are highly sought after due to the urgent need for vaccinations and other essential medical products to be delivered. The healthcare cold chain faced hitherto unheard-of difficulties in ensuring the safe and effective transportation of temperature-sensitive COVID-19 vaccinations, such as those that need to be kept at extremely low temperatures, like Pfizer-BioNTech’s mRNA vaccine.
Europe Healthcare Cold Chain Logistics Market Key Players:
Additionally, Some of the market key players are lloga, Biocair, Carrier Transicold, Cavalier Logistics, DB Schenker, DHL, Envirotainer, Kuehne + Nagel, Marken Ltd, Primafrio, and other.
Europe Healthcare Retail Logistics Market Segmentation:
The SPER Market Research report seeks to give market dynamics, demand, and supply forecasts for the years up to 2033. This report contains statistics on product type segment growth estimates and forecasts.
By Product: Based on the Product, Europe Healthcare Cold Chain Logistics Market is segmented as; Biopharmaceuticals, Vaccines, Clinical Trial Materials.
By Services: Based on the Services, Europe Healthcare Cold Chain Logistics Market is segmented as; Transportation, Storage, Packaging and Labelling, Others.
By End User: Based on the End User, Europe Healthcare Cold Chain Logistics Market is segmented as; Hospitals, Clinics and Pharmaceuticals, Biopharmaceutical, Biotechnology.
By Region: This research also includes data for Germany, France, Italy, Spain, UK, Rest of Europe.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.
For More Information, refer to below link:-
Europe Healthcare Cold Chain Logistics Market Revenue
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant — U.S.A.
SPER Market Research
+1-347-460-2899
